(REZI) Resideo Technologies - Overview
Stock: Thermostats, Detectors, Security
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 44.1% |
| Relative Tail Risk | -14.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.13 |
| Alpha | 44.80 |
| Character TTM | |
|---|---|
| Beta | 1.525 |
| Beta Downside | 1.871 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.06% |
| CAGR/Max DD | 0.53 |
Description: REZI Resideo Technologies January 11, 2026
Resideo Technologies Inc. (NYSE: REZI) designs, manufactures and distributes comfort, energy-management, and safety-and-security solutions across the United States, Europe and other international markets.
The company operates two primary segments: (1) Products & Solutions, which sells temperature- and humidity-control hardware, water- and air-treatment systems, smoke and CO detectors, residential security devices, video cameras, cloud-based services and related software under brands such as Honeywell Home, First Alert, Resideo, Braukmann and BRK; and (2) ADI Global Distribution, a wholesale channel that moves low-voltage security, fire, access-control, smart-home and networking products to contractors, integrators and retailers.
Resideo reaches end-users through a mixed-channel network of professional installers, distributors, OEMs, big-box retailers and e-commerce platforms, leveraging its brand equity to capture both DIY and B2B demand.
Key recent metrics (FY 2023): revenue of roughly $2.1 billion, adjusted EBITDA margin of about 10 %, and a year-over-year revenue growth of 4 % driven largely by a 15 % CAGR expansion in the global smart-home market and sustained residential renovation spending despite higher interest rates.
Macro-level drivers include tightening building-code requirements for energy efficiency, rising consumer adoption of connected-home devices, and the ongoing shortage of skilled HVAC installers that favors integrated, cloud-enabled solutions.
For a more granular financial breakdown and scenario analysis, you may want to explore ValueRay’s dedicated REZI valuation page.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -640.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.16 > 0.02 and ΔFCF/TA -21.39 > 1.0 |
| NWC/Revenue: 19.37% < 20% (prev 21.20%; Δ -1.83% < -1%) |
| CFO/TA -0.15 > 3% & CFO -1.23b > Net Income -640.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (154.0m) vs 12m ago 3.36% < -2% |
| Gross Margin: 28.72% > 18% (prev 0.28%; Δ 2844 % > 0.5%) |
| Asset Turnover: 91.10% > 50% (prev 79.16%; Δ 11.93% > 0%) |
| Interest Coverage Ratio: -4.03 > 6 (EBITDA TTM -264.0m / Interest Expense TTM 113.0m) |
Altman Z'' 0.88
| A: 0.18 (Total Current Assets 3.07b - Total Current Liabilities 1.63b) / Total Assets 8.19b |
| B: 0.03 (Retained Earnings 218.0m / Total Assets 8.19b) |
| C: -0.06 (EBIT TTM -455.0m / Avg Total Assets 8.16b) |
| D: 0.01 (Book Value of Equity 50.0m / Total Liabilities 5.42b) |
| Altman-Z'' Score: 0.88 = B |
Beneish M -2.95
| DSRI: 0.90 (Receivables 1.15b/1.10b, Revenue 7.43b/6.44b) |
| GMI: 0.97 (GM 28.72% / 27.86%) |
| AQI: 1.00 (AQ_t 0.57 / AQ_t-1 0.57) |
| SGI: 1.15 (Revenue 7.43b / 6.44b) |
| TATA: 0.07 (NI -640.0m - CFO -1.23b) / TA 8.19b) |
| Beneish M-Score: -2.95 (Cap -4..+1) = A |
What is the price of REZI shares?
Over the past week, the price has changed by +6.19%, over one month by +2.45%, over three months by +16.19% and over the past year by +65.29%.
Is REZI a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the REZI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 45 | 23.7% |
| Analysts Target Price | 45 | 23.7% |
| ValueRay Target Price | 39.6 | 8.9% |
REZI Fundamental Data Overview February 03, 2026
P/S = 0.6899
P/B = 2.2009
Revenue TTM = 7.43b USD
EBIT TTM = -455.0m USD
EBITDA TTM = -264.0m USD
Long Term Debt = 3.17b USD (from longTermDebt, last quarter)
Short Term Debt = 51.0m USD (from shortTermDebt, last fiscal year)
Debt = 3.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.82b USD (from netDebt column, last quarter)
Enterprise Value = 7.95b USD (5.13b + Debt 3.17b - CCE 345.0m)
Interest Coverage Ratio = -4.03 (Ebit TTM -455.0m / Interest Expense TTM 113.0m)
EV/FCF = -5.96x (Enterprise Value 7.95b / FCF TTM -1.33b)
FCF Yield = -16.77% (FCF TTM -1.33b / Enterprise Value 7.95b)
FCF Margin = -17.94% (FCF TTM -1.33b / Revenue TTM 7.43b)
Net Margin = -8.61% (Net Income TTM -640.0m / Revenue TTM 7.43b)
Gross Margin = 28.72% ((Revenue TTM 7.43b - Cost of Revenue TTM 5.30b) / Revenue TTM)
Gross Margin QoQ = 28.17% (prev 29.28%)
Tobins Q-Ratio = 0.97 (Enterprise Value 7.95b / Total Assets 8.19b)
Interest Expense / Debt = 1.20% (Interest Expense 38.0m / Debt 3.17b)
Taxrate = 47.51% (105.0m / 221.0m)
NOPAT = -238.8m (EBIT -455.0m * (1 - 47.51%)) [loss with tax shield]
Current Ratio = 1.88 (Total Current Assets 3.07b / Total Current Liabilities 1.63b)
Debt / Equity = 1.14 (Debt 3.17b / totalStockholderEquity, last quarter 2.77b)
Debt / EBITDA = -10.70 (negative EBITDA) (Net Debt 2.82b / EBITDA -264.0m)
Debt / FCF = -2.12 (negative FCF - burning cash) (Net Debt 2.82b / FCF TTM -1.33b)
Total Stockholder Equity = 3.01b (last 4 quarters mean from totalStockholderEquity)
RoA = -7.84% (Net Income -640.0m / Total Assets 8.19b)
RoE = -21.26% (Net Income TTM -640.0m / Total Stockholder Equity 3.01b)
RoCE = -7.36% (EBIT -455.0m / Capital Employed (Equity 3.01b + L.T.Debt 3.17b))
RoIC = -4.97% (negative operating profit) (NOPAT -238.8m / Invested Capital 4.81b)
WACC = 7.37% (E(5.13b)/V(8.30b) * Re(11.53%) + D(3.17b)/V(8.30b) * Rd(1.20%) * (1-Tc(0.48)))
Discount Rate = 11.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.35%
Fair Price DCF = unknown (Cash Flow -1.33b)
EPS Correlation: -0.22 | EPS CAGR: -47.24% | SUE: -4.0 | # QB: 0
Revenue Correlation: 75.24 | Revenue CAGR: 6.85% | SUE: -0.36 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.57 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.79 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+8.4% | Growth Revenue=+3.6%